News
Digitalization in clinical trials – curse or blessing?
Under the umbrella of this topic around 300 members and non-members of the BVMA (Bundesverband Medizinischer Auftragsinstitute e.V.) will come together in Munich on November 29th to discuss innovative technologies and regulatory changes in pharma and medical device jurisdiction.
Prof. Stephan Wnendt, CEO of MLM Medical Labs, will co-moderate the session about Good Practices, where, amongst others, an outlook from the view of authorities will be given and GCP hot topics presented.
MLM is very much looking forward to this annual symposium, which is always a very informative event in a nice setting and atmosphere.
Further information can be found on the BVMA website.
